Literature DB >> 1457951

Dialysate and blood flow dependence of diffusive solute clearance during CVVHD.

S Relton1, A Greenberg, P M Palevsky.   

Abstract

To define the flow dependence of diffusive solute clearance (Kd) during continuous venovenous hemodiafiltration (CVVHD), urea, creatinine, and phosphate clearance were measured during CVVHD, while ultrafiltration was minimized. Studies were performed using AN69, polyacrylonitrile (PAN), and polyamide (PA) hollow fiber hemofilters. To assess the dialysate flow dependence of Kd, clearances were measured at constant blood flow (QB), while dialysate inflow (QDi) was increased incrementally from 8.3 to 33.3 ml/min. Kd increased linearly for all three solutes using all membranes. To assess its blood flow dependence, Kd was measured at blood flows of 50, 75, 100, and 150 ml/min, while QDi was held constant at 33.3 ml/min. The PA membrane showed no flow dependence; for the other membranes, Kd was flow independent for QB > 100 ml/min. At all values of QB and QDi, clearances for the AN69 and PAN membranes were two to three times that of the PA membrane (p < 0.01). Lactate uptake increased with increasing QDi for all three membranes, but did not result in blood lactate accumulation. It is concluded that: 1) small molecule clearance is dialysate flow limited during CVVHD; 2) increasing QB beyond 100 ml/min is unnecessary for maintaining solute clearance; and 3) the PA membrane is unsuitable for CVVHD because of its low diffusive solute clearance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1457951     DOI: 10.1097/00002480-199207000-00127

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  7 in total

1.  Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.

Authors:  G R Matzke; R F Frye; M S Joy; P M Palevsky
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Proximally delivered dilute heparin does not improve circuit life in continuous venovenous haemodiafiltration.

Authors:  G D Leslie; I G Jacobs; G M Clarke
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440

Review 3.  How To Prescribe And Troubleshoot Continuous Renal Replacement Therapy: A Case-Based Review.

Authors:  Javier A Neyra; Lenar Yessayan; Melissa L Thompson Bastin; Keith M Wille; Ashita J Tolwani
Journal:  Kidney360       Date:  2020-12-14

4.  CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations.

Authors:  Anna Lorenzin; Francesco Garzotto; Alberta Alghisi; Mauro Neri; Dario Galeano; Stefania Aresu; Antonello Pani; Enrico Vidal; Zaccaroa Ricci; Luisa Murer; Stuart L Goldstein; Claudio Ronco
Journal:  Pediatr Nephrol       Date:  2016-04-30       Impact factor: 3.714

Review 5.  A review of continuous renal replacement therapy.

Authors:  C G Flynn
Journal:  Ir J Med Sci       Date:  1994-07       Impact factor: 1.568

6.  Dialysis Efficiency of AN69, a Semisynthetic Membrane Not Well Suited for Diffusion.

Authors:  M E Herrera-Gutiérrez; G Seller-Pérez; D Arias Verdu; C Jironda-Gallegos; M Martín-Velázquez; G Quesada-García
Journal:  ISRN Nephrol       Date:  2012-12-20

7.  The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill.

Authors:  Mychajlo Zakharchenko; Ferdinand Los; Helena Brodska; Martin Balik
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.